A higher baseline optical coherence tomography microstructural burden is associated with persistent central retinal thickening in eyes receiving intravitreal treatment for diabetic macular edema, according to findings from a retrospective cohort study. Researchers observed that cumulative structural abnormalities on baseline scans corresponded to increased odds of persistent edema at both three and six months post-treatment, even after accounting for initial central subfield thickness measurements.
The investigation addressed a recognized limitation in diabetic macular edema evaluation, where central subfield thickness quantifies edema severity but fails to describe accompanying retinal morphology. Because thickness metrics alone do not capture qualitative structural damage, the study examined whether evaluating baseline optical coherence tomography microstructural burden was associated with persistent central thickening following intravitreal treatment. By controlling for initial central subfield thickness, investigators aimed to clarify the specific contribution of baseline structural features to post-treatment anatomical persistence.
The research was conducted as a single-center retrospective cohort that evaluated 138 eyes from 76 patients undergoing intravitreal therapy. Patient care regimens included treatments with either anti-vascular endothelial growth factor agents or dexamethasone implants. Because participants could contribute both eyes to the evaluation, the study design accounted for inter-eye clustering while assessing anatomical responses across the clinical cohort.
To assess morphological damage on baseline optical coherence tomography, investigators implemented an unweighted scoring system ranging from 0 to 4 points. The score allocated one point for each of four defined structural features: foveal eversion, the presence of more than 30 hyperreflective foci, vitreomacular interface abnormality, and ellipsoid zone disruption. This scoring framework provided a concise and interpretable summary of accompanying baseline retinal abnormalities before the initiation of intravitreal therapy.
The primary study outcome was persistent central thickening, defined as a central subfield thickness of at least 300 micrometers measured at month 3, within a window of 45 to 135 days. A key secondary outcome evaluated the same threshold of persistent central thickening at month 6, within a window of 135 to 225 days. In their statistical approach, the investigators analyzed central subfield thickness continuously and used patient-clustered logistic generalized estimating equations to determine adjusted odds ratios per score point, controlling for patient age, sex, baseline central subfield thickness, and baseline visual acuity measured on the logarithm of the minimum angle of resolution scale.
Persistent central thickening occurred frequently among evaluated eyes, documented in 88 of 118 eyes, or 74.6 percent, at the month 3 assessment. By the month 6 evaluation, persistent thickening was identified in 64 of 92 eyes, representing 69.6 percent of the sample. Rates of persistent thickening rose in a stepwise pattern across increasing score groups at both intervals, with observed rates exceeding 90 percent among eyes exhibiting baseline microstructural scores of 3 or 4.
Multivariable modeling demonstrated that each one-point increase in the baseline microstructural burden score was associated with a more than twofold increase in the odds of persistent thickening. At month 3, the adjusted odds ratio was 2.30 per point, with a 95 percent confidence interval of 1.41 to 3.74. At month 6, the adjusted odds ratio was 2.42 per point, with a 95 percent confidence interval of 1.39 to 4.22. When evaluating central subfield thickness as a continuous measure, each score point was associated with an estimated 39.98 micrometers of additional thickening at month 6, with a 95 percent confidence interval of 8.33 to 71.64 micrometers, whereas the continuous estimate at month 3 did not reach statistical significance.
Sensitivity analyses confirmed that the observed associations remained directionally consistent when adjusting for treatment type and when repeatedly selecting one eye per patient. The authors characterized the investigation as an exploratory analysis, concluding that baseline optical coherence tomography microstructural burden is associated with persistent central thickening at 3 and 6 months after taking baseline central subfield thickness into account.
Subject of Research: Baseline optical coherence tomography microstructural burden and persistent central thickening in diabetic macular edema
Article Title: Baseline OCT microstructural burden associated with persistent central thickening after intravitreal treatment for diabetic macular edema
Article References: Li, R., Ma, L., Peng, C., Huang, Z., Ye, Y., Yan, M., & Song, Y. (2026). Baseline OCT microstructural burden associated with persistent central thickening after intravitreal treatment for diabetic macular edema. International Journal of Retina and Vitreous. https://doi.org/10.1186/s40942-026-00962-8
Image Credits: AI Generated
DOI: 10.1186/s40942-026-00962-8
Keywords: diabetic macular edema, optical coherence tomography, central subfield thickness, intravitreal therapy, anti-VEGF, dexamethasone implant, retinal microstructural burden, foveal eversion, hyperreflective foci, vitreomacular interface abnormality, ellipsoid zone disruption, persistent central thickening, retrospective cohort study, logMAR visual acuity, generalized estimating equations, retinal morphology
Cite Scienmag News
Phoebe Ingram. (November 17, 2026). Baseline OCT Microstructural Burden Associates With Persistent Retinal Thickening. Scienmag. https://scienmag.com/baseline-oct-microstructural-burden-associates-with-persistent-retinal-thickening/
Phoebe Ingram. "Baseline OCT Microstructural Burden Associates With Persistent Retinal Thickening." Scienmag, 17 November 2026, https://scienmag.com/baseline-oct-microstructural-burden-associates-with-persistent-retinal-thickening/. Accessed 17 November 2026.
Phoebe Ingram. "Baseline OCT Microstructural Burden Associates With Persistent Retinal Thickening." Scienmag. November 17, 2026. https://scienmag.com/baseline-oct-microstructural-burden-associates-with-persistent-retinal-thickening/








